Este blog é dedicado a consolidar informações valiosas sobre amiloidose e homenagear a vida tão preciosa, motivado pelo meu pai, estou ao seu lado em todos os desafios. Te amo pai.
"Pfizer is working closely with the relevant national health authorities across the EU to launch the new treatment and anticipates that health care professionals will be able to prescribe the treatment in European markets by early 2012."
Tafamidis was developed by the company FoldRx Pharmaceuticals cofounded by prof. Kelly, and acquired by Pfizer in 2010. For more information on earlier work leading to the drug, see http://www.scripps.edu/newsandviews/e_20090727/kelly.html.
"Pfizer is working closely with the relevant national health authorities across the EU to launch the new treatment and anticipates that health care professionals will be able to prescribe the treatment in European markets by early 2012."
ResponderExcluirTafamidis was developed by the company FoldRx Pharmaceuticals cofounded by prof. Kelly, and acquired by Pfizer in 2010. For more information on earlier work leading to the drug, see http://www.scripps.edu/newsandviews/e_20090727/kelly.html.